Abstract
BackgroundCervical carcinoma is one of the most common malignant tumors of the female reproductive system. Lymph nodes metastasis, the most common metastasis, which can be detected even in small-size tumor patients, results in worse prognosis. Therefore, it is of great significance to explore novel lymph nodes metastasis associated biomarkers, which can predict the prognosis and provide a good reference for clinical decision making in cervical carcinoma patients. However, systematic and comprehensive studies related to the key molecules in lymph node metastasis in cervical carcinoma patients are still absent.MethodsTranscriptome and clinical data of 307 cervical carcinoma patients were obtained from The Cancer Genome Atlas (TCGA). Then, survival of patients with and without lymph node metastasis was analyzed by Kaplan-Meier (K-M) curves. Differential expressed genes (DEGs) were detected between tumor and control samples using limma package and defined as lymph node metastasis related genes. Univariate and multivariate Cox regression analyses were carried out to screen robust prognostic gene signature. The risk score model and nomogram for predicting survival were constructed based on prognostic gene signature. The performance of the risk score model was evaluated by operating characteristic (ROC) curves. Based on risk score, patients were divided into low- and high- risk groups. DEGs, functional enrichment analysis and tumor microenvironment (immune infiltration and expressions of immune checkpoints) were detected in low- and high-risk groups.ResultsA total of 103 lymph node metastasis-associated genes were identified. Univariate and multivariate Cox regression analyses identified TEKT2, LPIN2, FABP4 and CXCL2 as prognostic gene signature. The risk score model was constructed and validated in cervical carcinoma patients. 345 DEGs identified between high- and low-risk groups were significantly enriched into immune-related biological processes. Furthermore, we found that the immune infiltration and expressions of immune checkpoints were significantly different between low- and high-risk groups.ConclusionOur study revealed that lymph node metastasis played an important role in the prognosis of cervical carcinoma patients. Furthermore, we established a risk score model based on lymph node metastasis related genes, which could accurately predict the survival of cervical carcinoma patients. Besides, our findings in tumor microenvironments of low- and high-risk groups improved our understanding of the relationship between lymph node metastasis related genes and cervical carcinoma.
Highlights
Uterine cervical cancer is a quite common female malignancy after thyroid cancer, with increasing trend of mortality in young females [1]
Our study revealed that lymph node metastasis played an important role in the prognosis of cervical carcinoma patients
We established a risk score model based on lymph node metastasis related genes, which could accurately predict the survival of cervical carcinoma patients
Summary
Uterine cervical cancer is a quite common female malignancy after thyroid cancer, with increasing trend of mortality in young females [1]. Lymph nodes metastasis is the most common phenomenon in cervical cancer metastasis and is an independent factor for poor prognosis of cervical cancer. We confirmed that lymph nodes metastasis was significantly associated with the up-regulation of immune biomarkers. Comprehensive study on lymph nodes metastasis in cervical cancer using bioinformatic strategy will provide better understanding of this phenomenon and lead to the identification of promising biomarkers in predicting the prognosis of cervical cancer patients. The most common metastasis, which can be detected even in small-size tumor patients, results in worse prognosis. It is of great significance to explore novel lymph nodes metastasis associated biomarkers, which can predict the prognosis and provide a good reference for clinical decision making in cervical carcinoma patients. Systematic and comprehensive studies related to the key molecules in lymph node metastasis in cervical carcinoma patients are still absent
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have